1. Home
  2. PMCB vs EEIQ Comparison

PMCB vs EEIQ Comparison

Compare PMCB & EEIQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMCB
  • EEIQ
  • Stock Information
  • Founded
  • PMCB 1996
  • EEIQ 2017
  • Country
  • PMCB United States
  • EEIQ United States
  • Employees
  • PMCB N/A
  • EEIQ 60
  • Industry
  • PMCB Biotechnology: Biological Products (No Diagnostic Substances)
  • EEIQ Other Consumer Services
  • Sector
  • PMCB Health Care
  • EEIQ Real Estate
  • Exchange
  • PMCB Nasdaq
  • EEIQ Nasdaq
  • Market Cap
  • PMCB 11.4M
  • EEIQ 11.3M
  • IPO Year
  • PMCB N/A
  • EEIQ 2021
  • Fundamental
  • Price
  • PMCB $1.76
  • EEIQ $0.85
  • Analyst Decision
  • PMCB
  • EEIQ
  • Analyst Count
  • PMCB 0
  • EEIQ 0
  • Target Price
  • PMCB N/A
  • EEIQ N/A
  • AVG Volume (30 Days)
  • PMCB 27.2K
  • EEIQ 3.2K
  • Earning Date
  • PMCB 03-17-2025
  • EEIQ 03-04-2025
  • Dividend Yield
  • PMCB N/A
  • EEIQ N/A
  • EPS Growth
  • PMCB N/A
  • EEIQ N/A
  • EPS
  • PMCB 0.74
  • EEIQ N/A
  • Revenue
  • PMCB N/A
  • EEIQ $8,153,546.00
  • Revenue This Year
  • PMCB N/A
  • EEIQ N/A
  • Revenue Next Year
  • PMCB N/A
  • EEIQ N/A
  • P/E Ratio
  • PMCB $2.37
  • EEIQ N/A
  • Revenue Growth
  • PMCB N/A
  • EEIQ 42.73
  • 52 Week Low
  • PMCB $1.39
  • EEIQ $0.60
  • 52 Week High
  • PMCB $2.58
  • EEIQ $1.44
  • Technical
  • Relative Strength Index (RSI)
  • PMCB 60.08
  • EEIQ 32.89
  • Support Level
  • PMCB $1.57
  • EEIQ $0.87
  • Resistance Level
  • PMCB $1.66
  • EEIQ $1.01
  • Average True Range (ATR)
  • PMCB 0.12
  • EEIQ 0.05
  • MACD
  • PMCB 0.02
  • EEIQ -0.01
  • Stochastic Oscillator
  • PMCB 68.89
  • EEIQ 0.00

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

About EEIQ EpicQuest Education Group International Limited

EpicQuest Education Group International Ltd provides comprehensive education solutions for domestic and international students interested in university and college degree programs in the U.S., Canada, and the UK. In addition, the company has a recruiting relationship with the regional campuses of Miami University of Ohio, where it maintains residential facilities, a full-service cafeteria, recreational facilities, shuttle buses, and an office for the regional campuses that provides study abroad and post-study services for its students; these facilities are not owned, maintained, operated or are part of Miami University. Company operated in three primary reportable segments foreign language education (QHI), foreign language education (RIL) and the professional training programs.

Share on Social Networks: